Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data in diabetic patients with acute hyperglycemia using NovoRapid™ FlexPen™ as per normal clinical practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin Aspart

Criteria

Inclusion Criteria:

• Patients with diabetes mellitus (according to product labelling)

Exclusion Criteria:

• Hypoglycaemia

• Hypersensitivity to insulin aspart or to any of the excipients (according to product labelling)